CATARACT SURGERY AND LENS IMPLANTATION: Edited by Natalie A. AfshariManagement of cataract in the setting of uveitis a review of the current literatureMoshirfar, Majida,b,c; Somani, Anisha N.d; Motlagh, Mahsaw N.e; Ronquillo, Yasmyne C.cAuthor Information aDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake bUtah Lions Eye Bank, Murray cHoopes Durrie Rivera Research Center, Hoopes Vision, Draper, Utah dMcGovern Medical School at the University of Texas Health Science Center at Houston, Houston, Texas eThe University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA Correspondence to Majid Moshirfar, MD, Medical Director Hoopes Durrie Rivera Research Center, Hoopes Vision, Draper, UT 84020, USA. Tel: +1 801 568 0200; fax: +1 801 563 0200; e-mail: firstname.lastname@example.org Current Opinion in Ophthalmology: January 2020 - Volume 31 - Issue 1 - p 3-9 doi: 10.1097/ICU.0000000000000626 Buy Metrics Abstract Purpose of review This review aims to cover the preoperative planning, intraoperative considerations, and postoperative management that aids in successful outcomes of patients with cataract and uveitis. Disease-specific management and pediatric management will also be addressed. Recent findings Dexamethasone implants appear to be a safe and effective addition to standard steroid treatment in decreasing the incidence of postoperative cystoid macular edema (CME). Intravitreal steroids and topical difluprednate have shown utility in CME treatment. Summary Cataract surgery in eyes with uveitis is generally safe and effective if inflammation is well controlled; however, complication rates are still higher than in eyes without uveitis. Future investigations should delineate outcomes for eyes with different etiologies of uveitis, and further research is needed to adequately control inflammation and avoid postoperative complications. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.